Copyright

Corresponding author

References

Hide All

1 Bekelman, JE, Li, Y, Gross, CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289: 454–65.

2 Lundh, A, Sismondo, S, Lexchin, J, Busuioc, OA, Bero, L. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2012; 12: MR000033.

3 Lexchin, J, Bero, LA, Djulbegovic, B, Clark, O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167–70.

4 Thompson, DF. Understanding financial conflicts of interest. N Engl J Med 1993; 329: 573–6.

5 Melander, H, Ahlqvist-Rastad, J, Meijer, G, Beermann, B. Evidence b(i)ased medicine–selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003; 326: 1171–3.

6 Turner, EH, Matthews, AM, Linardatos, E, Tell, RA, Rosenthal, R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358: 252–60.

7 Gartlehner, G, Morgan, L, Thieda, P, Fleg, A. The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: secondary analysis of a systematic review. J Clin Epidemiol 2010; 63: 117–25.

8 Baker, CB, Johnsrud, MT, Crismon, ML, Rosenheck, RA, Woods, SW. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 2003; 183: 498–506.

9 Cuijpers, P, Sijbrandij, M, Koole, SL, Andersson, G, Beekman, AT, Reynolds, CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 2013; 12: 137–48.

10 Imel, ZE, Malterer, MB, McKay, KM, Wampold, BE. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord 2008; 110: 197–206.

11 Cuijpers, P, Turner, EH, Mohr, DC, Hofmann, SG, Andersson, G, Berking, M, et al Comparison of psychotherapies for adult depression to pill placebo control groups: a meta-analysis. Psychol Med 2014; 44: 685–95.

12 National Institute for Health and Clinical Excellence. Treatment and Management of Depression in Adults, Including Adults with a Chronic Physical Health Problem. NICE, 2009.

13 Cuijpers, P, van Straten, A, Warmerdam, L, Andersson, G. Psychological treatment of depression: a meta-analytic database of randomized studies. BMC Psychiatry 2008; 8: 36.

14 Higgins, JPT, Altman, DG, Gotzsche, PC, Juni, P, Moher, D, Oxman, AD, et al The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.

15 Hedges, LV, Olkin, I. Statistical Methods for Meta-Analysis. Academic Press, 1985.

16 Borenstein, M, Hedges, LV, Higgins, JPT, Rothstein, HR. Introduction to Meta-Analysis. Wiley, 2009.

17 Higgins, JPT, Thompson, SG, Deeks, JJ, Altman, DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–60.

18 Ioannidis, JPA, Patsopoulos, NA, Evangelou, E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007; 335: 914–6.

19 Orsini, N, Bottai, M, Higgins, J, Buchan, I. HETEROGI: Stata Module to Quantify Heterogeneity in a Meta-Analysis. Boston College Department of Economics, 2006 (http://econpapers.repec.org/software/bocbocode/s449201.htm).

20 Duval, S, Tweedie, R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–63.

21 Borenstein, M, Hedges, LV, Higgins, JPT, Rothstein, HR. Introduction to Meta-Analysis. Wiley, 2009.

22 Barber, JP, Barrett, MS, Gallop, R, Rynn, MA, Rickels, K. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry 2012; 73: 66–73.

23 Barrett, JE, Williams, JW, Oxman, TE, Frank, E, Katon, W, Sullivan, M, et al Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract 2001; 50: 405–12.

24 Bedi, N, Chilvers, C, Churchill, R, Dewey, M, Duggan, C, Fielding, K, et al Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry 2000; 177: 312–8.

25 Blackburn, IM, Moore, RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry 1997; 171: 328–34.

26 Blom, MBJ, Jonker, K, Dusseldorp, E, Spinhoven, P, Hoencamp, E, Haffmans, J, et al Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychother Psychosom 2007; 76: 289–97.

27 Browne, G, Steiner, M, Roberts, J, Gafni, A, Byrne, C, Dunn, E, et al Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 2002; 68: 317–30.

28 David, D, Szentagotai, A, Lupu, V, Cosman, D. Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: a randomized clinical trial, posttreatment outcomes, and six-month follow-up. J Clin Psychol 2008; 64: 728–46.

29 Dekker, JJM, Koelen, JA, Van, HL, Schoevers, RA, Peen, J, Hendriksen, M, et al Speed of action: the relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. J Affect Disord 2008; 109: 183–8.

30 DeRubeis, RJ, Hollon, SD, Amsterdam, JD, Shelton, RC, Young, PR, Salomon, RM, et al Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62: 409–16.

31 Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, et al Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74: 658–70.

32 Dunlop, BW, Kelley, ME, Mletzko, TC, Velasquez, CM, Craighead, WE, Mayberg, HS. Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res 2012; 46: 375–81.

33 Dunner, DL, Schmaling, KB, Hendrickson, H, Becker, J, Lehman, A, Bea, C. Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression 1996; 4: 34–41.

34 Elkin, I, Shea, MT, Watkins, JT, Imber, SD, Sotsky, SM, Collins, JF, et al National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989; 46: 971–82; discussion 983.

35 Faramarzi, M, Alipor, A, Esmaelzadeh, S, Kheirkhah, F, Poladi, K, Pash, H. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine. J Affect Disord 2008; 108: 159–64.

36 Finkenzeller, DW, Zobel, I, Rietz, S, Schramm, E, Berger, M. Interpersonelle Psychotherapie und Pharmakotherapie bei Post-Stroke-Depression. Nervenarzt 2009; 80: 805–12.

37 Frank, E, Cassano, GB, Rucci, P, Thompson, WK, Kraemer, HC, Fagiolini, A, et al Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med 2011; 41: 151–62.

38 Hegerl, U, Hautzinger, M, Mergl, R, Kohnen, R, Schütze, M, Scheunemann, W, et al Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010; 13: 31–44.

39 Hollon, SD, DeRubeis, RJ, Evans, MD, Wiemer, MJ, Garvey, MJ, Grove, WM, et al Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Arch Gen Psychiatry 1992; 49: 774–81.

40 Jarrett, RB, Schaffer, M, McIntire, D, Witt-Browder, A, Kraft, D, Risser, RC. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56: 431–7.

41 Keller, MB, McCullough, JP, Klein, DN, Arnow, B, Dunner, DL, Gelenberg, AL, et al A Comparison of Nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New Eng J Med 2000; 342: 1462–70.

42 Kennedy, SH, Konarski, JZ, Segal, ZV, Lau, MA, Bieling, PJ, McIntyre, RS, et al Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 2007; 164: 778–88.

43 Markowitz, JC, Kocsis, JH, Bleiberg, KL, Christos, PJ, Sacks, M. A comparative trial of psychotherapy and pharmacotherapy for ‘pure’ dysthymic patients. J Affect Disord 2005; 89: 167–75.

44 Martin, SD, Martin, E, Rai, SS, Richardson, MA, Royall, R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001; 58: 641–8.

45 Mcknight, DL, Nelson-Gray, RO, Barnhill, J. Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behavior Therapy 1992; 23: 99–111.

46 McLean, PD, Hakstian, AR. Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol 1979; 47: 818–36.

47 Menchetti, M, Rucci, P, Bortolotti, B, Bombi, A, Scocco, P, Kraemer, HC, et al Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial. Br J Psychiatry 2014; 204: 144–50.

48 Miranda, J, Chung, JY, Green, BL, Krupnick, J, Siddique, J, Revicki, DA, et al Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA 2003; 290: 57–65.

49 Mohr, DC, Boudewyn, AC, Goodkin, DE, Bostrom, A, Epstein, L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001; 69: 942–9.

50 Moradveisi, L, Huibers, MJH, Renner, F, Arasteh, M, Arntz, A. Behavioural activation v. antidepressant medication for treating depression in Iran: randomised trial. Br J Psychiatry 2013; 202: 204–11.

51 Murphy, GE, Simons, AD, Wetzel, RD, Lustman, PJ. Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. Arch Gen Psychiatry 1984; 41: 33–41.

52 Mynors-Wallis, LM, Gath, DH, Day, A, Baker, F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000; 320: 26–30.

53 Mynors-Wallis, LM, Gath, DH, Lloyd-Thomas, AR, Tomlinson, D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310: 441–5.

54 Parker, G, Blanch, B, Paterson, A, Hadzi-Pavlovic, D, Sheppard, E, Manicavasagar, V, et al The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: a 12-week single-blind randomized study. Acta Psychiatr Scand 2013; 128: 271–81.

55 Quilty, LC, McBride, C, Bagby, RM. Evidence for the cognitive mediational model of cognitive behavioural therapy for depression. Psychol Med 2008; 38: 1531–41.

56 Rush, AJ, Beck, AT, Kovacs, M, Hollon, S. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cogn Ther Res 1977; 1: 17–37.

57 Salminen, JK, Karlsson, H, Hietala, J, Kajander, J, Aalto, S, Markkula, J, et al Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom 2008; 77: 351–7.

58 Schulberg, HC, Block, MR, Madonia, MJ, Scott, CP, Rodriguez, E, Imber, SD, et al Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry 1996; 53: 913–9.

59 Scott, AL, Freeman, CP. Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 1992; 304: 883–7.

60 Shamsaei, F, Rahimi, A, Zarabian, MK, Sedehi, M. Efficacy of pharmacotherapy and cognitive therapy, alone and in combination in major depressive disorder. Hong Kong J Psychiatry 2008; 18: 76.

61 Sharp, DJ, Chew-Graham, C, Tylee, A, Lewis, G, Howard, L, Anderson, I, et al A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess 2010; 14: iii–iv, ix–xi, 1–153.

62 Sloane, RB, Staples, FR, Schneider, LS. Interpersonal therapy vs. nortriptyline for depression in the elderly. In Clinical and Pharmacological Studies in Psychiatric Disorders (ed Burrows, GD, Norman, TR and Dennerstein, L): 344–6. John Libbey, 1985.

63 Thompson, LW, Coon, DW, Gallagher-Thompson, D, Sommer, BR, Koin, D. Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry 2001; 9: 225–40.

64 Weissman, MM, Prusoff, BA, Dimascio, A, Neu, C, Goklaney, M, Klerman, GL The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 1979; 136: 555–8.

65 Williams, JW, Barrett, J, Oxman, T, Frank, E, Katon, W, Sullivan, M, et al Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 2000; 284: 1519–26.

66 Zu, S, Xiang, Y-T, Liu, J, Zhang, L, Wang, G, Ma, X, et al A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders. J Affect Disord 2014; 152–4: 262–7.

67 Imel, ZE, Malterer, MB, McKay, KM, Wampold, BE. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord 2008; 110: 197–206.

68 Cuijpers, P, Turner, EH, Koole, SL, van Dijke, A, Smit, F. What Is the threshold for a clinically relevant effect? The case of major depressive disorders. Depress Anxiety 2014; 31: 374–8.

69 Cipriani, A, Furukawa, TA, Salanti, G, Geddes, JR, Higgins, JP, Churchill, R, et al Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373: 746–58.

70 Cuijpers, P, van Straten, A, Andersson, G, van Oppen, P. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008; 76: 909–22.

71 Okike, K, Kocher, MS, Mehlman, CT, Bhandari, M. Industry-sponsored research. Injury 2008; 39: 666–80.

72 Eisner, M, Humphreys, DK, Wilson, P, Gardner, F. Disclosure of financial conflicts of interests in interventions to improve child psychosocial health: a cross-sectional study. PLoS One 2015; 10: e0142803.